Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Nutr Sci ; 4: e35, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26495126

RESUMO

Population-based studies have shown an inverse association between dietary menaquinones (MK-n, vitamin K2) intake, coronary calcification and CHD risk, suggesting a potential role of vitamin K in vascular health. To date, the effects of increased menaquinone intake on (markers of) vascular health have been investigated using predominantly food supplements. Dairy products contain many essential nutrients and can serve as a good matrix for food fortification in order to support health. We were therefore interested to study the effects of a menaquinone-fortified yogurt drink (menaquinone as menaquinone-7 (MK-7); 28 µg MK-7/yogurt drink) on vitamin K status and markers of vascular health. The yogurt drink was also fortified with n-3 PUFA, vitamin D, vitamin C, Ca and Mg to support vascular and/or general health. Healthy men (n 32) and postmenopausal women (n 28) with a mean age of 56 (sd 5) years received either basic or fortified yogurt drink twice per d for 12 weeks. MK-7 was efficiently absorbed from the fortified yogurt drink. Levels of circulating MK-7 were significantly increased from 0·28 to 1·94 ng/ml. In accordance, intake of the fortified yogurt drink improved vitamin K status, as measured by significant decreases in uncarboxylated osteocalcin and desphospho-uncarboxylated matrix Gla-protein. No effects were, however, seen on markers of inflammation, endothelial dysfunction and lipid metabolism. In summary, consumption of a yogurt drink fortified with low doses of among others MK-7 for 3 months significantly improved vitamin K status in a healthy population.

2.
Br J Nutr ; 108(9): 1652-7, 2012 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-22289649

RESUMO

Vitamin K is required for the carboxylation of Gla-proteins in the liver (coagulation factors) and extra-hepatic tissues, such as bone (osteocalcin, OC), and arterial wall (matrix Gla-protein, MGP). Although the coagulation factors are essentially fully carboxylated under normal conditions, 10-40 % of OC and MGP remains undercarboxylated. We were therefore interested to study the dose-response effects of extra intake of menaquinones on the carboxylation of the extra-hepatic Gla-proteins. A total of forty-two healthy Dutch men and women aged between 18 and 45 years were randomised into seven groups to receive: placebo capsules or menaquinone-7 (MK-7) capsules at a daily dose of 10, 20, 45, 90, 180 or 360 µg. Circulating uncarboxylated OC (ucOC), carboxylated OC (cOC) and desphospho-uncarboxylated MGP were measured by ELISA. The ucOC:cOC ratio was calculated from circulating ucOC and cOC values. Endogenous thrombin potential and peak height were determined by calibrated automated thrombography. To increase the statistical power, we collapsed the treatment groups into three dosage groups: placebo, low-dose supplementation (doses below RDA, Commission Directive 2008/100/EC), and high-dose supplementation (doses around RDA, Commission Directive 2008/100/EC). MK-7 supplementation at doses in the order of the RDA (Commission Directive 2008/100/EC) increased the carboxylation of circulating OC and MGP. No adverse effects on thrombin generation were observed. Extra MK-7 intake at nutritional doses around the RDA (Commission Directive 2008/100/EC) improved the carboxylation of the extra-hepatic vitamin K-dependent proteins. Whether this improvement contributes to public health, i.e. increasing the protection against age-related diseases needs further investigation in specifically designed intervention trials.


Assuntos
Coagulação Sanguínea , Suplementos Nutricionais/efeitos adversos , Hemostáticos/uso terapêutico , Estado Nutricional , Vitamina K 2/análogos & derivados , Deficiência de Vitamina K/dietoterapia , Adulto , Algoritmos , Testes de Coagulação Sanguínea , Descarboxilação , Método Duplo-Cego , Feminino , Hemostáticos/administração & dosagem , Hemostáticos/efeitos adversos , Hemostáticos/farmacocinética , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Osteocalcina/sangue , Osteocalcina/metabolismo , Projetos Piloto , Vitamina K/sangue , Vitamina K 2/administração & dosagem , Vitamina K 2/efeitos adversos , Vitamina K 2/farmacocinética , Vitamina K 2/uso terapêutico , Deficiência de Vitamina K/sangue , Deficiência de Vitamina K/metabolismo , Adulto Jovem
3.
Blood ; 109(8): 3279-83, 2007 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-17158229

RESUMO

Vitamin K is a cofactor in the production of blood coagulation factors (in the liver), osteocalcin (in bone), and matrix Gla protein (cartilage and vessel wall). Accumulating evidence suggests that for optimal bone and vascular health, relatively high intakes of vitamin K are required. The synthetic short-chain vitamin K(1) is commonly used in food supplements, but recently the natural long-chain menaquinone-7 (MK-7) has also become available as an over-the-counter (OTC) supplement. The purpose of this paper was to compare in healthy volunteers the absorption and efficacy of K(1) and MK-7. Serum vitamin K species were used as a marker for absorption and osteocalcin carboxylation as a marker for activity. Both K(1) and MK-7 were absorbed well, with peak serum concentrations at 4 hours after intake. A major difference between the 2 vitamin K species is the very long half-life time of MK-7, resulting in much more stable serum levels, and accumulation of MK-7 to higher levels (7- to 8-fold) during prolonged intake. MK-7 induced more complete carboxylation of osteocalcin, and hematologists should be aware that preparations supplying 50 mug/d or more of MK-7 may interfere with oral anticoagulant treatment in a clinically relevant way.


Assuntos
Coenzimas/farmacocinética , Suplementos Nutricionais , Vitamina K 1/farmacocinética , Vitamina K 2/análogos & derivados , Vitaminas/farmacocinética , Absorção , Adulto , Fatores de Coagulação Sanguínea/metabolismo , Osso e Ossos/metabolismo , Cartilagem/metabolismo , Coenzimas/administração & dosagem , Coenzimas/metabolismo , Feminino , Humanos , Fígado/metabolismo , Masculino , Osteocalcina/metabolismo , Fatores de Tempo , Vitamina K 1/administração & dosagem , Vitamina K 1/metabolismo , Vitamina K 2/administração & dosagem , Vitamina K 2/metabolismo , Vitamina K 2/farmacocinética , Vitaminas/administração & dosagem , Vitaminas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA